Gland Pharma Ltd (GLAND) — Announcement | 8 September 2026

8 September 2026 · BSE 🔴 High Importance Neutral

By StockFin Research Team•AI-Assisted Analysis•Source: BSE/NSE Filings

📢 Key Event

Gland Pharma announces investor meeting schedule with DSP Mutual Fund on September 11, 2026.

💡 Investor Takeaway

Retail investors can now engage directly with management through scheduled one-on-one meetings, improving transparency and access to company insights.

Gland Pharma announced its schedule for analyst and institutional investor meetings, including a one-on-one with DSP Mutual Fund on September 11, 2026, as part of ongoing stakeholder engagement. The filing confirms the company will host multiple investor sessions in the coming week, reflecting active outreach to key shareholders. These meetings provide retail investors with direct access to management, enhancing transparency and offering opportunities to discuss financial performance and growth strategy.

📄 View Original Announcement (PDF)

📊 Stock Analysis — GLAND ✨ Ask AI About This

About Gland Pharma Ltd (GLAND)

Healthcare · Pharmaceuticals · Listed on BSE

Market Cap: ₹49,299.85 CrP/E: 43.6ROE: 10.9%ROCE: 15.2%Div Yield: 0.67%

View full GLAND stock details →

📡 Get AI alerts when GLAND files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track GLAND — Free

💡 Ask AI about this filing

"When will Q3 financial results be announced?""What is the revenue growth outlook for FY27?""How does management view competition in the API market?"

Ask AI Free →

📊 More GLAND filings

🟡 Board Meeting — 13 September 2026Gland Pharma's board addressed fines from NSE and BSE totaling **₹70,000 each** for a 34-day technic...
🔴 Corporate Action — 13 September 2026Gland Pharma announced on September 13, 2026, that its board approved acquiring 100% of Gland Pharma...
🟡 Board Meeting — 13 September 2026Gland Pharma announced on September 13, 2026 that its Board approved the grant of 5,90,249 stock opt...
🔴 Corporate Action — 13 September 2026Gland Pharma announced the allotment of 42,393 equity shares under ESOP 2025 and 1,800 shares under ...
🟡 Board Meeting — 13 September 2026Gland Pharma announced the board approved acquiring 100% of Gland Pharma USA Inc. for USD 5,01,208 i...

See all GLAND filings →

🔥 Also filed on 8 September 2026

500357Rama Paper Mills LtdAnnual Report 514028Rajkamal Synthetics LtdAnnual Report INDIANORGFutura Polyesters LtdFinancial Results UYFINCORPU. Y. Fincorp LtdAnnual Report APOLLOApollo Micro Systems LtdAnnual Report 544201Dindigul Farm Product LtdCorporate Action

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when GLAND files new disclosures

Track GLAND filings, board meetings, and corporate actions. Free email alerts at 5 PM.